Biotechnology
Usa
Therapies
Neurological
Acquire
Acorda
M&A Advisory
Lazard
Full Credential Description
Acorda Therapeutics. United States. Announced Date 24/09/2014. Closed Date 22/10/2014. Deal value: $525m. Acorda Therapeutics to acquire Civitas Therapeutics. Industry: Acorda Therapeutics is a biotechnology company focused on developing therapies for neurological disorders.